StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Pacira Pharmaceuticals (PCRX) PT Raised to $60 at Needham & Company
November 1, 2018 3:49 PM
Needham & Company analyst Serge ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Next Articles
Pacira Pharmaceuticals (PCRX) PT Raised to $46 at Mizuho Securities Following 3Q
November 5, 2018 7:16 AM
Pacira Pharmaceuticals (PCRX) PT Raised to $60 at RBC Capital
November 2, 2018 7:14 AM